Chair: E. Chavakis (Frankfurt am Main), H. Langer (Tübingen)
| 08:30 | (V22) | Controlling FOXO signalling in the vascular endothelium |
| T. Sugino (Bad Nauheim) | ||
| 08:40 | Discussion | |
| 08:45 | (V23) | Role of SHARPIN, an integrin inhibitor, in angiogenesis |
| F. Bonini (Frankfurt am Main) | ||
| 08:55 | Discussion | |
| 09:00 | (V24) | Thrombocytes in metabolic syndrome |
| D. Dürschmied (Freiburg im Breisgau) | ||
| 09:10 | Discussion | |
| 09:15 | (V25) | Platelet complement anaphylatoxin receptors as new players in vascular disease |
| R. J. Sauter (Tübingen) | ||
| 09:25 | Discussion | |
| 09:30 | (V26) | Modulation of monocytes in response to cardiac disease |
| F. Leuschner (Heidelberg) | ||
| 09:40 | Discussion | |
| 09:45 | Final discussion |
